{"id":"https://openalex.org/W4361237177","doi":"https://doi.org/10.1158/0008-5472.c.6509193","title":"Data from Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance","display_name":"Data from Anti-Jagged Immunotherapy Inhibits MDSCs and Overcomes Tumor-Induced Tolerance","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361237177","doi":"https://doi.org/10.1158/0008-5472.c.6509193"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.c.6509193","doi":"https://doi.org/10.1158/0008-5472.c.6509193","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6509193","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/0008-5472.c.6509193","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109808527","display_name":"Rosa A. Sierra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rosa A. Sierra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091644433","display_name":"Jimena Trillo-Tinoco","orcid":"https://orcid.org/0000-0002-1240-9650","observed_orcids":["https://orcid.org/0000-0002-1240-9650"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jimena Trillo-Tinoco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026503075","display_name":"Eslam T. Mohamed","orcid":"https://orcid.org/0000-0003-3360-118X","observed_orcids":["https://orcid.org/0000-0003-3360-118X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eslam Mohamed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060468233","display_name":"Lolie C. Yu","orcid":"https://orcid.org/0000-0003-3898-5047","observed_orcids":["https://orcid.org/0000-0003-3898-5047"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lolie Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000876055","display_name":"Bhagelu R. Achyut","orcid":"https://orcid.org/0000-0001-5670-6983","observed_orcids":["https://orcid.org/0000-0001-5670-6983"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bhagelu R. Achyut","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011681716","display_name":"Ali S. Arbab","orcid":"https://orcid.org/0000-0003-2902-3671","observed_orcids":["https://orcid.org/0000-0003-2902-3671"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ali Arbab","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022017562","display_name":"Jennifer W. Bradford","orcid":"https://orcid.org/0000-0002-1337-8382","observed_orcids":["https://orcid.org/0000-0002-1337-8382"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jennifer W. Bradford","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056296095","display_name":"Barbara A. Osborne","orcid":"https://orcid.org/0000-0001-8255-0556","observed_orcids":["https://orcid.org/0000-0001-8255-0556"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara A. Osborne","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041301571","display_name":"Lucio Miele","orcid":"https://orcid.org/0000-0002-5853-7287","observed_orcids":["https://orcid.org/0000-0002-5853-7287"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lucio Miele","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032410036","display_name":"Paulo C. Rodr\u0131\u0301guez","orcid":"https://orcid.org/0000-0001-7480-6566","observed_orcids":["https://orcid.org/0000-0001-7480-6566"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paulo C. Rodriguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11313","display_name":"Immune cells in cancer","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.006599999964237213,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.9480000138282776},{"id":"https://openalex.org/keywords/t-cell-suppression","display_name":"T cell suppression","score":0.8450000286102295},{"id":"https://openalex.org/keywords/nf-kappab-p65-signaling","display_name":"NF-\u03baB p65 signaling","score":0.8050000071525574},{"id":"https://openalex.org/keywords/arginase-1","display_name":"arginase-1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/inducible-nitric-oxide-synthase","display_name":"inducible nitric oxide synthase","score":0.9279999732971191},{"id":"https://openalex.org/keywords/cd8-t-cell-infiltration","display_name":"CD8+ T cell infiltration","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.7250000238418579}],"concepts":[{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6991940140724182},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6969467997550964},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6271405220031738},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.584193766117096},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.5351560711860657},{"id":"https://openalex.org/C55721878","wikidata":"https://www.wikidata.org/wiki/Q15220362","display_name":"Myeloid-derived Suppressor Cell","level":4,"score":0.5071842670440674},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5003325939178467},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4703303277492523},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4305422306060791},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40813255310058594},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3982153832912445},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.3475773334503174},{"id":"https://openalex.org/C179185449","wikidata":"https://www.wikidata.org/wiki/Q219699","display_name":"Suppressor","level":3,"score":0.29429739713668823},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.1381407082080841},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.11731690168380737}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/0008-5472.c.6509193","doi":"https://doi.org/10.1158/0008-5472.c.6509193","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6509193","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/0008-5472.c.6509193","doi":"https://doi.org/10.1158/0008-5472.c.6509193","is_oa":true,"landing_page_url":"https://doi.org/10.1158/0008-5472.c.6509193","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2756171891","https://openalex.org/W4392724338","https://openalex.org/W2123900004","https://openalex.org/W2118793009","https://openalex.org/W2107002386","https://openalex.org/W2389269445","https://openalex.org/W2401267803","https://openalex.org/W4392680062","https://openalex.org/W2066615317","https://openalex.org/W2166530259"],"abstract_inverted_index":{"Abstract":[0],"Myeloid-derived":[1],"suppressor":[2],"cells":[3,85,98,111,117],"(MDSC)":[4],"are":[5],"a":[6,144],"major":[7],"obstacle":[8],"to":[9,17,154,163],"promising":[10],"forms":[11],"of":[12,33,56,64,81,92,96,109,135,147,152,168],"cancer":[13,116,169],"immunotherapy,":[14],"but":[15],"tools":[16],"broadly":[18,164],"limit":[19],"their":[20],"immunoregulatory":[21],"effects":[22],"remain":[23],"lacking.":[24],"In":[25],"this":[26],"study,":[27],"we":[28],"assessed":[29],"the":[30,34,51,62,79,90,150,166],"therapeutic":[31],"effect":[32],"humanized":[35],"anti\u2013Jagged1/2-blocking":[36],"antibody":[37],"CTX014":[38,46],"on":[39],"MDSC-mediated":[40,156],"T-cell":[41,76,157],"suppression":[42,158],"in":[43,58,102,124,159],"tumor-bearing":[44],"mice.":[45],"decreased":[47],"tumor":[48,100,119],"growth,":[49],"affected":[50],"accumulation":[52],"and":[53,60,69,88,132],"tolerogenic":[54],"activity":[55],"MDSCs":[57,125],"tumors,":[59,87,160],"inhibited":[61],"expression":[63],"immunosuppressive":[65],"factors":[66,128],"arginase":[67],"I":[68],"iNOS.":[70],"Consequently,":[71],"anti-Jagged":[72],"therapy":[73],"overcame":[74],"tumor-induced":[75],"tolerance,":[77],"increased":[78],"infiltration":[80],"reactive":[82],"CD8+":[83],"T":[84],"into":[86],"enhanced":[89],"efficacy":[91,167],"T-cell\u2013based":[93],"immunotherapy.":[94],"Depletion":[95],"MDSC-like":[97,110],"restored":[99],"growth":[101],"mice":[103,114],"treated":[104],"with":[105,115,161],"anti-Jagged,":[106],"whereas":[107],"coinjection":[108],"from":[112],"anti\u2013Jagged-treated":[113],"delayed":[118],"growth.":[120],"Jagged1/2":[121],"was":[122],"induced":[123],"by":[126],"tumor-derived":[127],"via":[129],"NFkB-p65":[130,136],"signaling,":[131],"conditional":[133],"deletion":[134],"blocked":[137],"MDSC":[138],"function.":[139],"Collectively,":[140],"our":[141],"results":[142],"offer":[143],"preclinical":[145],"proof":[146],"concept":[148],"for":[149],"use":[151],"anti-Jagged1/2":[153],"reprogram":[155],"implications":[162],"improve":[165],"therapy.":[170],"Cancer":[171],"Res;":[172],"77(20);":[173],"5628\u201338.":[174],"\u00a92017":[175],"AACR.":[176]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-03-31T00:00:00"}